ABL1 and neoplasm: Despite ligand expression, which results in differences in in vitro cytotoxicity assays, the subcutaneous tumor growth of v‐abl+ cells and the progression of Abelson‐induced leukemia was unaltered irrespective of whether NK cells express NKG2D.